福瑞达(600223) - 2024 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2024 was ¥877,188,685.48, representing a decrease of 4.82% compared to the same period last year[2]. - The net profit attributable to shareholders for the same period was ¥43,913,792.10, down 7.76% year-on-year[2]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥39,275,925.66, a decrease of 12.15%[2]. - Year-to-date operating revenue reached ¥2,802,563,091.30, reflecting a decline of 17.45% compared to the previous year[2]. - The basic earnings per share for the reporting period was ¥0.04, a decrease of 26.09% compared to the previous year[2]. - The weighted average return on equity for the year-to-date was 4.14%, down 2.07 percentage points from the previous year[2]. - For the first nine months of 2024, the company achieved operating revenue of RMB 2.803 billion and a net profit attributable to the parent company of RMB 171 million[10]. - Total revenue for the first three quarters of 2024 was CNY 2,802,563,091.30, a decrease of 17.4% compared to CNY 3,394,861,033.85 in the same period of 2023[18]. - Total revenue for the first three quarters of 2024 was CNY 2,750,224,359.66, a decrease from CNY 3,687,918,796.70 in the same period of 2023, representing a decline of approximately 25.4%[22]. - Net profit for Q3 2024 was CNY 209,546,814.29, down from CNY 301,724,176.02 in Q3 2023, reflecting a decrease of about 30.6%[21]. - Operating profit for Q3 2024 was CNY 242,009,090.78, compared to CNY 350,259,097.52 in Q3 2023, indicating a decline of approximately 30.9%[20]. Assets and Liabilities - The total assets at the end of the reporting period were ¥6,101,487,099.77, a decrease of 21.95% from the end of the previous year[3]. - The company’s total assets as of September 30, 2024, amounted to RMB 6.101 billion, with net assets attributable to the parent company of RMB 4.084 billion[10]. - Total assets decreased to CNY 6,101,487,099.77 as of September 30, 2024, down from CNY 7,817,827,107.25 at the end of 2023, a decline of 21.9%[17]. - Total liabilities decreased to CNY 1,344,443,202.56 in Q3 2024, compared to CNY 3,137,686,013.71 in Q3 2023, a reduction of 57.1%[16]. - The company's equity attributable to shareholders increased to CNY 4,084,410,634.25 as of September 30, 2024, compared to CNY 4,014,767,628.09 at the end of 2023, a rise of 1.7%[17]. - Short-term borrowings decreased significantly to CNY 357,041,959.64 in Q3 2024 from CNY 705,223,652.78 in Q3 2023, a drop of 49.3%[16]. Cash Flow - The net cash flow from operating activities for the year-to-date was ¥61,382,368.06, down 81.28% year-on-year[6]. - The net cash flow from operating activities for Q3 2024 was ¥61,382,368.06, a decrease of 81.24% compared to ¥327,923,984.43 in Q3 2023[23]. - The total cash inflow from investing activities reached ¥3,144,584,567.90, significantly up from ¥1,477,753,540.60 in the same period last year, marking a 112.67% increase[23]. - The net cash flow from investing activities was ¥3,033,931,469.71, compared to ¥1,286,526,781.43 in Q3 2023, indicating a growth of 135.67%[23]. - The cash inflow from financing activities totaled ¥202,213,516.67, down from ¥1,857,479,650.94 in Q3 2023, reflecting an 89.09% decrease[23]. - The net cash flow from financing activities was -¥1,955,777,620.27, slightly worse than -¥1,892,930,155.52 in the previous year[23]. - The ending balance of cash and cash equivalents was ¥2,826,444,010.60, compared to ¥1,359,154,882.95 at the end of Q3 2023, showing a 108.56% increase[24]. - The total cash outflow from operating activities was ¥2,854,066,223.57, down from ¥3,673,023,967.03 in Q3 2023, a decrease of 22.25%[23]. - The company paid ¥338,008,929.40 in employee-related cash payments, down from ¥417,792,272.02 in the same quarter last year, a reduction of 19.06%[23]. - The cash paid for taxes was ¥218,083,031.38, significantly lower than ¥462,910,141.51 in Q3 2023, indicating a decrease of 53.19%[23]. - The cash received from the disposal of subsidiaries and other business units was ¥2,982,039,258.30, a substantial increase from ¥1,379,905,982.23 in the previous year, representing a growth of 116.00%[23]. Segment Performance - The cosmetics segment generated revenue of RMB 1.708 billion, a year-on-year increase of 3.25%, with a gross margin of 62.32%[10]. - The medical segment reported revenue of RMB 370 million, a year-on-year decrease of 7.42%, with a gross margin of 50.48%[11]. - The raw materials and additives segment recorded revenue of RMB 249 million, a year-on-year decrease of 1.96%, with a gross margin of 39.39%[12]. - The company launched nine functional food products in the new business expansion, including drinks made from traditional Chinese herbs[11]. - The sales of the "Billion Yuan" cream project increased by 54% year-on-year, contributing to the growth of the same series of products[10]. Shareholder Information - The company’s major shareholder, Shandong Commercial Group Co., Ltd., holds 51.62% of the shares, with 195,000,000 shares pledged[7]. - The company’s major shareholder, Shandong Commercial Group, holds approximately 32.44% of the total share capital[9]. Future Outlook - The company reported a net profit margin decline due to reduced revenue and increased costs, impacting overall profitability[18]. - Future outlook includes potential market expansion and new product development strategies to recover from the revenue decline experienced in 2024[18].